• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消化炎症:蛋白水解失调的作用。

Digestive Inflammation: Role of Proteolytic Dysregulation.

机构信息

Microbiota Interaction with Human and Animal Team (MIHA), Micalis Institute, AgroParisTech, Université Paris-Saclay, INRAE, F-78350 Jouy-en-Josas, France.

Department of Clinical Sciences, Nantes-Atlantic College of Veterinary Medicine and Food Sciences (Oniris), University of Nantes, 101 Route de Gachet, 44300 Nantes, France.

出版信息

Int J Mol Sci. 2021 Mar 10;22(6):2817. doi: 10.3390/ijms22062817.

DOI:10.3390/ijms22062817
PMID:33802197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7999743/
Abstract

Dysregulation of the proteolytic balance is often associated with diseases. Serine proteases and matrix metalloproteases are involved in a multitude of biological processes and notably in the inflammatory response. Within the framework of digestive inflammation, several studies have stressed the role of serine proteases and matrix metalloproteases (MMPs) as key actors in its pathogenesis and pointed to the unbalance between these proteases and their respective inhibitors. Substantial efforts have been made in developing new inhibitors, some of which have reached clinical trial phases, notwithstanding that unwanted side effects remain a major issue. However, studies on the proteolytic imbalance and inhibitors conception are directed toward host serine/MMPs proteases revealing a hitherto overlooked factor, the potential contribution of their bacterial counterpart. In this review, we highlight the role of proteolytic imbalance in human digestive inflammation focusing on serine proteases and MMPs and their respective inhibitors considering both host and bacterial origin.

摘要

蛋白酶平衡失调通常与疾病有关。丝氨酸蛋白酶和基质金属蛋白酶参与了多种生物过程,特别是在炎症反应中。在消化炎症的框架内,有几项研究强调了丝氨酸蛋白酶和基质金属蛋白酶 (MMPs) 在其发病机制中的关键作用,并指出了这些蛋白酶与其各自抑制剂之间的不平衡。尽管存在不良副作用等问题,但人们在开发新抑制剂方面做出了巨大努力,其中一些已进入临床试验阶段。然而,对蛋白酶失衡和抑制剂概念的研究主要针对宿主丝氨酸/MMPs 蛋白酶,揭示了一个迄今为止被忽视的因素,即其细菌对应物的潜在贡献。在这篇综述中,我们强调了蛋白酶失衡在人类消化炎症中的作用,重点关注丝氨酸蛋白酶和 MMPs 及其各自的抑制剂,同时考虑了宿主和细菌的来源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/7999743/b168f3e30162/ijms-22-02817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/7999743/9169177c5660/ijms-22-02817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/7999743/b168f3e30162/ijms-22-02817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/7999743/9169177c5660/ijms-22-02817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a442/7999743/b168f3e30162/ijms-22-02817-g002.jpg

相似文献

1
Digestive Inflammation: Role of Proteolytic Dysregulation.消化炎症:蛋白水解失调的作用。
Int J Mol Sci. 2021 Mar 10;22(6):2817. doi: 10.3390/ijms22062817.
2
Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation.丝氨酸蛋白酶在炎症性肠病治疗中的研究进展:关注胃肠道炎症。
FASEB J. 2020 Jun;34(6):7270-7282. doi: 10.1096/fj.202000031RR. Epub 2020 Apr 19.
3
Siropins, novel serine protease inhibitors from gut microbiota acting on human proteases involved in inflammatory bowel diseases.西罗平,一种源自肠道微生物群的新型丝氨酸蛋白酶抑制剂,作用于参与炎症性肠病的人类蛋白酶。
Microb Cell Fact. 2016 Nov 29;15(1):201. doi: 10.1186/s12934-016-0596-2.
4
Matrix metalloproteases role in bowel inflammation and inflammatory bowel disease: an up to date review.基质金属蛋白酶在肠道炎症和炎症性肠病中的作用:最新综述
Inflamm Bowel Dis. 2014 Dec;20(12):2379-93. doi: 10.1097/MIB.0000000000000163.
5
Signaling pathways induced by serine proteases to increase intestinal epithelial barrier function.丝氨酸蛋白酶诱导的增加肠道上皮屏障功能的信号通路。
PLoS One. 2017 Jul 3;12(7):e0180259. doi: 10.1371/journal.pone.0180259. eCollection 2017.
6
Protean proteases: at the cutting edge of lung diseases.多变的蛋白酶:在肺部疾病的前沿。
Eur Respir J. 2017 Feb 8;49(2). doi: 10.1183/13993003.01200-2015. Print 2017 Feb.
7
[Role of the matrix metalloproteinases activity in inflammatory bowel disease].[基质金属蛋白酶活性在炎症性肠病中的作用]
Pol Merkur Lekarski. 2010 Dec;29(174):387-9.
8
Gut Serpinome: Emerging Evidence in IBD.肠道丝氨酸蛋白酶抑制剂组:炎症性肠病的新证据。
Int J Mol Sci. 2021 Jun 4;22(11):6088. doi: 10.3390/ijms22116088.
9
Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.下一代基质金属蛋白酶抑制剂——新策略带来新前景。
Biochim Biophys Acta Mol Cell Res. 2017 Nov;1864(11 Pt A):1927-1939. doi: 10.1016/j.bbamcr.2017.06.009. Epub 2017 Jun 19.
10
Serine protease inhibitors to treat inflammation: a patent review (2011-2016).用于治疗炎症的丝氨酸蛋白酶抑制剂:专利综述(2011 - 2016年)
Expert Opin Ther Pat. 2018 Feb;28(2):93-110. doi: 10.1080/13543776.2018.1406478. Epub 2017 Dec 5.

引用本文的文献

1
PERRC: Protease Engineering with Reactant Residence Time Control.PERRC:通过反应物停留时间控制进行蛋白酶工程
ACS Synth Biol. 2025 Jun 20;14(6):2241-2253. doi: 10.1021/acssynbio.5c00154. Epub 2025 May 19.
2
Matrix Metalloproteinases: Pathophysiologic Implications and Potential Therapeutic Targets in Cardiovascular Disease.基质金属蛋白酶:心血管疾病中的病理生理意义及潜在治疗靶点
Biomolecules. 2025 Apr 17;15(4):598. doi: 10.3390/biom15040598.
3
Abnormal Expression of Proteolytic Stress-Related Proteins and Protective Effect of Fibrinolytic Enzymes in Prion Diseases.

本文引用的文献

1
Mast Cell Tryptase Promotes Inflammatory Bowel Disease-Induced Intestinal Fibrosis.肥大细胞类胰蛋白酶促进炎症性肠病诱导的肠道纤维化。
Inflamm Bowel Dis. 2021 Jan 19;27(2):242-255. doi: 10.1093/ibd/izaa125.
2
Serine proteases at the cutting edge of IBD: Focus on gastrointestinal inflammation.丝氨酸蛋白酶在炎症性肠病治疗中的研究进展:关注胃肠道炎症。
FASEB J. 2020 Jun;34(6):7270-7282. doi: 10.1096/fj.202000031RR. Epub 2020 Apr 19.
3
Venous thromboembolism in inflammatory bowel disease.炎症性肠病中的静脉血栓栓塞症。
朊病毒疾病中蛋白水解应激相关蛋白的异常表达及纤溶酶的保护作用
Transbound Emerg Dis. 2025 Feb 26;2025:9527934. doi: 10.1155/tbed/9527934. eCollection 2025.
4
An batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors.一项分批培养研究,旨在评估健康和肠易激综合征粪便供体的粪便微生物群对人乳寡糖的发酵情况。
Gut Microbiome (Camb). 2025 Mar 20;6:e4. doi: 10.1017/gmb.2025.2. eCollection 2025.
5
PERRC: Protease Engineering with Reactant Residence Time Control.PERRC:通过反应物停留时间控制进行蛋白酶工程
bioRxiv. 2025 Mar 4:2025.03.02.641063. doi: 10.1101/2025.03.02.641063.
6
A1AT dysregulation of metabolically stressed hepatocytes by Kupffer cells drives MASH and fibrosis.库普弗细胞对代谢应激肝细胞的α1抗胰蛋白酶调节异常会导致代谢相关脂肪性肝炎和肝纤维化。
Exp Mol Med. 2025 Feb;57(2):450-465. doi: 10.1038/s12276-025-01408-1. Epub 2025 Feb 12.
7
Industrial diet intervention modulates the interplay between gut microbiota and host in semi-stray dogs.工业饮食干预调节半流浪犬肠道微生物群与宿主之间的相互作用。
Anim Microbiome. 2024 Nov 21;6(1):69. doi: 10.1186/s42523-024-00357-w.
8
Effect of protease supplementation on amino acid digestibility of soybean meal fed to growing-finishing pigs in two different ages.蛋白酶补充剂对饲喂给两个不同年龄段生长育肥猪的豆粕氨基酸消化率的影响。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae345.
9
Proteolysis Assays With Conserved or Aminofluorescein-Labeled Red Blood Cells.用保守或氨基荧光素标记的红细胞进行蛋白水解分析。
Biomed Res Int. 2024 Sep 27;2024:7919329. doi: 10.1155/2024/7919329. eCollection 2024.
10
The Current Molecular and Cellular Landscape of Chronic Obstructive Pulmonary Disease (COPD): A Review of Therapies and Efforts towards Personalized Treatment.慢性阻塞性肺疾病(COPD)的当前分子和细胞格局:治疗方法及个性化治疗进展综述
Proteomes. 2024 Aug 16;12(3):23. doi: 10.3390/proteomes12030023.
World J Gastroenterol. 2020 Mar 28;26(12):1231-1241. doi: 10.3748/wjg.v26.i12.1231.
4
Fecal Serine Protease Profiling in Inflammatory Bowel Diseases.粪便丝氨酸蛋白酶谱分析在炎症性肠病中的应用。
Front Cell Infect Microbiol. 2020 Feb 4;10:21. doi: 10.3389/fcimb.2020.00021. eCollection 2020.
5
The Interplay Between Genetic Risk Factors and Proteolytic Dysregulation in the Pathophysiology of Inflammatory Bowel Disease.遗传风险因素与蛋白水解失调在炎症性肠病发病机制中的相互作用。
J Crohns Colitis. 2020 Sep 7;14(8):1149-1161. doi: 10.1093/ecco-jcc/jjaa033.
6
Novel, Self-Assembling Dimeric Inhibitors of Human β Tryptase.新型人源β-色氨酸酶二聚体抑制剂。
J Med Chem. 2020 Mar 26;63(6):3004-3027. doi: 10.1021/acs.jmedchem.9b01689. Epub 2020 Feb 27.
7
Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology.基于结构的设计和嘧啶及 1,2,4-三唑并[4,3-a]嘧啶基基质金属蛋白酶-10/13 抑制剂的优化——通过 Dimroth 重排实现靶向多药理学
Bioorg Chem. 2020 Mar;96:103616. doi: 10.1016/j.bioorg.2020.103616. Epub 2020 Jan 25.
8
Binding Loop Substitutions in the Cyclic Peptide SFTI-1 Generate Potent and Selective Chymase Inhibitors.结合环取代在环肽 SFTI-1 中产生有效的和选择性糜酶抑制剂。
J Med Chem. 2020 Jan 23;63(2):816-826. doi: 10.1021/acs.jmedchem.9b01811. Epub 2020 Jan 9.
9
Faecal neutrophil elastase-antiprotease balance reflects colitis severity.粪便中性粒细胞弹性蛋白酶-抗蛋白酶平衡反映结肠炎的严重程度。
Mucosal Immunol. 2020 Mar;13(2):322-333. doi: 10.1038/s41385-019-0235-4. Epub 2019 Nov 26.
10
Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.针对 MMP-9 的战斗策略;通过 Ugi 双酰胺合成发现具有 PI3K/AKT 信号抑制和 caspase 3/7 激活作用的新型非羟肟酸 MMP-9 抑制剂。
Eur J Med Chem. 2020 Jan 15;186:111875. doi: 10.1016/j.ejmech.2019.111875. Epub 2019 Nov 10.